MiR-223, a miRNA specific for IL-4-activated macrophages, could be transported from macrophages to breast cancer cells via exosomes (63) to promote breast cancer cell invasion via modulation of the β-catenin pathway. The gene discussed is IL4; the disease is breast carcinoma.